{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:13:04Z","timestamp":1794406384928,"version":"4.9.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.leukres.2023.107391","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T11:34:02Z","timestamp":1695209642000},"page":"107391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["TET2 somatic copy number alterations and allelic imbalances in chronic myelomonocytic leukemia"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7062-2644","authenticated-orcid":false,"given":"Mark","family":"Gurney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia T.","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Gliem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Knudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aref","family":"Al-Kali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseema","family":"Gangat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terra","family":"Lasho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek A.","family":"Mangaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy M.","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal M.","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2023.107391_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2023.107391_bib2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107391_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/bloodadvances.2018024216","article-title":"Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia","volume":"3","author":"Awada","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2023.107391_bib4","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2012-06-440347","article-title":"Clonal architecture of chronic myelomonocytic leukemias","volume":"121","author":"Itzykson","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107391_bib5","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/s41375-023-01887-z","article-title":"Single cell proteogenomic analysis of aberrant monocytosis in TET2 mutant premalignant and malignant hematopoiesis","volume":"37","author":"Lasho","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2023.107391_bib6","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1182\/blood-2010-12-325241","article-title":"Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies","volume":"118","author":"Li","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107391_bib7","unstructured":"Bernard E., Hasserjan R.P., Greenberg P.L., Arango Ossa J.E., Creignou M., Nannya Y., et al. Genomic Classification of Myelodysplastic Syndromes. 17th International Congress on Myelodysplastic Syndromes, Marseille: 2023."},{"key":"10.1016\/j.leukres.2023.107391_bib8","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.3324\/haematol.2015.126227","article-title":"Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype","volume":"100","author":"Ahn","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2023.107391_bib9","first-page":"4476","article-title":"Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromes","volume":"10","author":"Jiang","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.leukres.2023.107391_bib10","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41375-019-0690-7","article-title":"Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients","volume":"34","author":"Coltro","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2023.107391_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2019-123047","article-title":"Mutant TET2 allele dosage affects response to 5-azacitidine in acute myeloid leukemia","volume":"134","author":"Stoelzel","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107391_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-022-01404-6","article-title":"Vitamin C boosts DNA demethylation in TET2 germline mutation carriers","volume":"15","author":"Taira","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.leukres.2023.107391_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2141.2009.07757.x","article-title":"Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies","volume":"146","author":"MacIejewski","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2023.107391_bib14","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","article-title":"Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes","volume":"26","author":"Bernard","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.leukres.2023.107391_bib15","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41375-022-01652-8","article-title":"High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance","volume":"36","author":"Yang","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2023.107391_bib16","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3390\/cancers13081947","article-title":"A single-run next-generation sequencing (Ngs) assay for the simultaneous detection of both gene mutations and large chromosomal abnormalities in patients with myelodysplastic syndromes (mds) and related myeloid neoplasms","volume":"13","author":"Liquori","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.leukres.2023.107391_bib17","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid."},{"key":"10.1016\/j.leukres.2023.107391_bib18","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2019.222323","article-title":"EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia","volume":"105","author":"Stasik","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2023.107391_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030839","article-title":"Role of CBL mutations in cancer and non-malignant phenotype","volume":"14","author":"Leardini","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.leukres.2023.107391_bib20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jha2.651","article-title":"Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype","volume":"4","author":"Mallo","year":"2023","journal-title":"EJHaem"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623006562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623006562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:04:45Z","timestamp":1758935085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212623006562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":20,"alternative-id":["S0145212623006562"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107391","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TET2 somatic copy number alterations and allelic imbalances in chronic myelomonocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107391"}}